Earnings Feed
Start Free
Home/Filings/4/0001209191-14-060754
4//SEC Filing

Vitae Pharmaceuticals, Inc 4

Accession 0001209191-14-060754

CIK 0001157602operating
View on SEC.govCompany Profile

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 9:03 PM ET

Size

37.0 KB

Accession

0001209191-14-060754

Insider Transaction Report

Form 4
Period: 2014-09-29
Vitae Pharmaceuticals, IncVTAE
HIRSCH RUSSELL C
10% Owner
Transactions
  • Conversion

    Common Stock

    2014-09-29+1,530,269→ 1,823,767 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2014-09-29+76,949→ 1,900,716 total(indirect: See Footnote)
  • Conversion

    Series A-2 Preferred Stock

    2014-09-29−173,912→ 0 total(indirect: See Footnote)
    → Common Stock (261,977 underlying)
  • Conversion

    Common Stock

    2014-09-29+261,977→ 293,498 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2014-09-29+102,301→ 395,799 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2014-09-29$8.00/sh+671,807$5,374,456→ 2,572,523 total(indirect: See Footnote)
  • Conversion

    Series B Preferred Stock

    2014-09-29−1,530,269→ 0 total(indirect: See Footnote)
    → Common Stock (1,530,269 underlying)
  • Conversion

    Series B Preferred Stock

    2014-09-29−102,301→ 0 total(indirect: See Footnote)
    → Common Stock (102,301 underlying)
  • Conversion

    Series C Preferred Stock

    2014-09-29−76,949→ 0 total(indirect: See Footnote)
    → Common Stock (76,949 underlying)
Holdings

  • Common Stock

    (indirect: See Footnote)
    31,520
PROSPECT VENTURE PARTNERS LP
10% Owner
Transactions
  • Conversion

    Common Stock

    2014-09-29+102,301→ 395,799 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2014-09-29+76,949→ 1,900,716 total(indirect: See Footnote)
  • Conversion

    Series B Preferred Stock

    2014-09-29−102,301→ 0 total(indirect: See Footnote)
    → Common Stock (102,301 underlying)
  • Conversion

    Series A-2 Preferred Stock

    2014-09-29−173,912→ 0 total(indirect: See Footnote)
    → Common Stock (261,977 underlying)
  • Conversion

    Common Stock

    2014-09-29+261,977→ 293,498 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2014-09-29+1,530,269→ 1,823,767 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2014-09-29$8.00/sh+671,807$5,374,456→ 2,572,523 total(indirect: See Footnote)
  • Conversion

    Series B Preferred Stock

    2014-09-29−1,530,269→ 0 total(indirect: See Footnote)
    → Common Stock (1,530,269 underlying)
  • Conversion

    Series C Preferred Stock

    2014-09-29−76,949→ 0 total(indirect: See Footnote)
    → Common Stock (76,949 underlying)
Holdings

  • Common Stock

    (indirect: See Footnote)
    31,520
SCHNELL DAVID
10% Owner
Transactions
  • Purchase

    Common Stock

    2014-09-29$8.00/sh+671,807$5,374,456→ 2,572,523 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2014-09-29+1,530,269→ 1,823,767 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2014-09-29+76,949→ 1,900,716 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2014-09-29+102,301→ 395,799 total(indirect: See Footnote)
  • Conversion

    Series A-2 Preferred Stock

    2014-09-29−173,912→ 0 total(indirect: See Footnote)
    → Common Stock (261,977 underlying)
  • Conversion

    Series B Preferred Stock

    2014-09-29−102,301→ 0 total(indirect: See Footnote)
    → Common Stock (102,301 underlying)
  • Conversion

    Series C Preferred Stock

    2014-09-29−76,949→ 0 total(indirect: See Footnote)
    → Common Stock (76,949 underlying)
  • Conversion

    Common Stock

    2014-09-29+261,977→ 293,498 total(indirect: See Footnote)
  • Conversion

    Series B Preferred Stock

    2014-09-29−1,530,269→ 0 total(indirect: See Footnote)
    → Common Stock (1,530,269 underlying)
Holdings

  • Common Stock

    (indirect: See Footnote)
    31,520
PROSPECT MANAGEMENT CO II LLC
10% Owner
Transactions
  • Conversion

    Series B Preferred Stock

    2014-09-29−1,530,269→ 0 total(indirect: See Footnote)
    → Common Stock (1,530,269 underlying)
  • Conversion

    Series A-2 Preferred Stock

    2014-09-29−173,912→ 0 total(indirect: See Footnote)
    → Common Stock (261,977 underlying)
  • Conversion

    Common Stock

    2014-09-29+76,949→ 1,900,716 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2014-09-29$8.00/sh+671,807$5,374,456→ 2,572,523 total(indirect: See Footnote)
  • Conversion

    Series C Preferred Stock

    2014-09-29−76,949→ 0 total(indirect: See Footnote)
    → Common Stock (76,949 underlying)
  • Conversion

    Series B Preferred Stock

    2014-09-29−102,301→ 0 total(indirect: See Footnote)
    → Common Stock (102,301 underlying)
  • Conversion

    Common Stock

    2014-09-29+261,977→ 293,498 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2014-09-29+102,301→ 395,799 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2014-09-29+1,530,269→ 1,823,767 total(indirect: See Footnote)
Holdings

  • Common Stock

    (indirect: See Footnote)
    31,520
PROSPECT MANAGEMENT CO LLC
10% Owner
Transactions
  • Conversion

    Series B Preferred Stock

    2014-09-29−102,301→ 0 total(indirect: See Footnote)
    → Common Stock (102,301 underlying)
  • Purchase

    Common Stock

    2014-09-29$8.00/sh+671,807$5,374,456→ 2,572,523 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2014-09-29+102,301→ 395,799 total(indirect: See Footnote)
  • Conversion

    Series B Preferred Stock

    2014-09-29−1,530,269→ 0 total(indirect: See Footnote)
    → Common Stock (1,530,269 underlying)
  • Conversion

    Series A-2 Preferred Stock

    2014-09-29−173,912→ 0 total(indirect: See Footnote)
    → Common Stock (261,977 underlying)
  • Conversion

    Common Stock

    2014-09-29+1,530,269→ 1,823,767 total(indirect: See Footnote)
  • Conversion

    Series C Preferred Stock

    2014-09-29−76,949→ 0 total(indirect: See Footnote)
    → Common Stock (76,949 underlying)
  • Conversion

    Common Stock

    2014-09-29+261,977→ 293,498 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2014-09-29+76,949→ 1,900,716 total(indirect: See Footnote)
Holdings

  • Common Stock

    (indirect: See Footnote)
    31,520
PROSPECT VENTURE PARTNERS II LP
10% Owner
Transactions
  • Conversion

    Common Stock

    2014-09-29+261,977→ 293,498 total(indirect: See Footnote)
  • Conversion

    Series A-2 Preferred Stock

    2014-09-29−173,912→ 0 total(indirect: See Footnote)
    → Common Stock (261,977 underlying)
  • Conversion

    Common Stock

    2014-09-29+102,301→ 395,799 total(indirect: See Footnote)
  • Conversion

    Series B Preferred Stock

    2014-09-29−102,301→ 0 total(indirect: See Footnote)
    → Common Stock (102,301 underlying)
  • Conversion

    Series B Preferred Stock

    2014-09-29−1,530,269→ 0 total(indirect: See Footnote)
    → Common Stock (1,530,269 underlying)
  • Conversion

    Series C Preferred Stock

    2014-09-29−76,949→ 0 total(indirect: See Footnote)
    → Common Stock (76,949 underlying)
  • Conversion

    Common Stock

    2014-09-29+1,530,269→ 1,823,767 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2014-09-29$8.00/sh+671,807$5,374,456→ 2,572,523 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2014-09-29+76,949→ 1,900,716 total(indirect: See Footnote)
Holdings

  • Common Stock

    (indirect: See Footnote)
    31,520
Footnotes (6)
  • [F1]Each outstanding share of Series A-2 Preferred Stock automatically converted on a 1:1.50638118 basis into the Issuer's common stock, immediately prior to the Issuer's initial public offering, for no additional consideration.
  • [F2]The reportable securities are owned by Prospect Venture Partners, L.P. ("PVP"). Prospect Management Co., L.L.C. ("PMC") is the general partner of PVP. David Schnell ("Schnell") is the managing member of PMC. Each of PMC and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
  • [F3]The reportable securities are owned by Prospect Venture Partners II, L.P. ("PVP II"). Prospect Management Co. II, L.L.C. ("PMC II") is the general partner of PVP II. Russell Hirsch ("Hirsch") and Schnell are the managing members of PMC II. Each of PMC II, Hirsch and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
  • [F4]Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted on a 1:1 basis into the Issuer's common stock, immediately prior to the Issuer's initial public offering, for no additional consideration.
  • [F5]The reportable securities are owned by PVP, as Nominee. PMC is the general partner of PVP. Schnell is the managing member of PMC. Each of PMC and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
  • [F6]The reportable securities are owned by PVP II, as Nominee. PMC II is the general partner of PVP II. Hirsch and Schnell are the managing members of PMC II. Each of PMC II, Hirsch and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.

Documents

1 file

Issuer

Vitae Pharmaceuticals, Inc

CIK 0001157602

→
Entity typeoperating

Related Parties

1
  • filerCIK 0001157602

Filing Metadata

Form type
4
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 9:03 PM ET
Size
37.0 KB
View on SEC.gov